| Deducing the N-and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 A Shajahan, NT Supekar, AS Gleinich, P Azadi Glycobiology 30 (12), 981-988, 2020 | 564* | 2020 |
| Synthetic receptors for the high‐affinity recognition of O‐GlcNAc derivatives P Rios, TS Carter, TJ Mooibroek, MP Crump, M Lisbjerg, M Pittelkow, ... Angewandte Chemie 128 (10), 3448-3453, 2016 | 94 | 2016 |
| Distinct roles of N-and O-glycans in cellulase activity and stability A Amore, BC Knott, NT Supekar, A Shajahan, P Azadi, P Zhao, L Wells, ... Proceedings of the National Academy of Sciences 114 (52), 13667-13672, 2017 | 88 | 2017 |
| Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist ABM Abdel‐Aal, V Lakshminarayanan, P Thompson, N Supekar, ... Chembiochem 15 (10), 1508-1513, 2014 | 80 | 2014 |
| Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen M Movahedin, TM Brooks, NT Supekar, N Gokanapudi, GJ Boons, ... Glycobiology 27 (7), 677-687, 2017 | 71 | 2017 |
| Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide P Thompson, V Lakshminarayanan, NT Supekar, JM Bradley, PA Cohen, ... Chemical communications 51 (50), 10214-10217, 2015 | 62 | 2015 |
| Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment N Martínez-Sáez, NT Supekar, MA Wolfert, IA Bermejo, ... Chemical science 7 (3), 2294-2301, 2016 | 44 | 2016 |
| Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein NT Supekar, A Shajahan, AS Gleinich, DS Rouhani, C Heiss, DG Chapla, ... Glycobiology 31 (9), 1080-1092, 2021 | 40 | 2021 |
| Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands F Marcelo, N Supekar, F Corzana, JC van der Horst, IM Vuist, D Live, ... Journal of Biological Chemistry 294 (4), 1300-1311, 2019 | 40 | 2019 |
| MUC1 vaccines, comprised of glycosylated or non-glycosylated peptides or tumor-derived MUC1, can circumvent immunoediting to control tumor growth in MUC1 transgenic mice V Lakshminarayanan, NT Supekar, J Wei, DB McCurry, AC Dueck, ... PloS one 11 (1), e0145920, 2016 | 39 | 2016 |
| Tool for rapid analysis of glycopeptide by permethylation via one-pot site mapping and glycan analysis A Shajahan, NT Supekar, C Heiss, M Ishihara, P Azadi Analytical chemistry 89 (20), 10734-10743, 2017 | 36 | 2017 |
| High-throughput automated micro-permethylation for glycan structure analysis A Shajahan, N Supekar, C Heiss, P Azadi Analytical chemistry 91 (2), 1237-1240, 2018 | 28 | 2018 |
| Glycosylation is vital for industrial performance of hyperactive cellulases D Chung, NS Sarai, BC Knott, N Hengge, JF Russell, JM Yarbrough, ... ACS sustainable chemistry & engineering 7 (5), 4792-4800, 2019 | 23 | 2019 |
| Mass spectrometric method for the unambiguous profiling of cellular dynamic glycosylation A Shajahan, NT Supekar, H Wu, AM Wands, G Bhat, A Kalimurthy, ... ACS chemical biology 15 (10), 2692-2701, 2020 | 20 | 2020 |
| Sequence-specific mucins for glycocalyx engineering H Pan, MJ Colville, NT Supekar, P Azadi, MJ Paszek ACS synthetic biology 8 (10), 2315-2326, 2019 | 20 | 2019 |
| SARS-CoV-2 Nucleocapsid protein is decorated with multiple N-and O-glycans NT Supekar, A Shajahan, AS Gleinich, D Rouhani, C Heiss, P Azadi BioRxiv, 2020.08. 26.269043, 2020 | 18 | 2020 |
| Regulating colonic dendritic cells by commensal glycosylated large surface layer protein A to sustain gut homeostasis against pathogenic inflammation Y Ge, M Gong, M Zadeh, J Li, JR Abbott, W Li, L Morel, R Sonon, ... Mucosal immunology 13 (1), 34-46, 2020 | 15 | 2020 |
| Simplifying glycan profiling through a high-throughput micropermethylation strategy A Shajahan, NT Supekar, D Chapla, C Heiss, KW Moremen, P Azadi SLAS TECHNOLOGY: Translating Life Sciences Innovation 25 (4), 367-379, 2020 | 14 | 2020 |
| Synthesis and immunological evaluation of a multicomponent cancer vaccine candidate containing a long MUC1 glycopeptide NT Supekar, V Lakshminarayanan, CJ Capicciotti, A Sirohiwal, ... ChemBioChem 19 (2), 121-125, 2018 | 14 | 2018 |
| Structural basis of Blastomyces Endoglucanase-2 adjuvancy in anti-fungal and -viral immunity L dos Santos Dias, HE Dobson, BK Bakke, GC Kujoth, J Huang, EM Kohn, ... PLoS Pathogens 17 (3), e1009324, 2021 | 7 | 2021 |
